CO17 How to Assess Nationwide Population-Based Clinical Benefit of Treatments Using Public Information? Immunotherapies Case Study
Abstract
Authors
V. Grumberg F.E. Cotte A.F. Gaudin I. Borget
V. Grumberg F.E. Cotte A.F. Gaudin I. Borget
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now